Skip to main content
. 2015 Jul 29;16(9):701–706. doi: 10.5152/AnatolJCardiol.2015.6325

Table 1.

Baseline characteristics of case and control groups

Case (n=27) Control (n=30) P
Age, years 12.24±4.37 12.83±6.12 *0.744
Gender (M/F), n 12/15 15/15 *0.678
Weight, kg 47.48±19.79 44.56±21.65 *0.514
Height, cm 149.68±19.79 146.74±18.54 *0.728
BMI, kg/m2 20.22±5.24 19.93±5.86 *0.918
SBP, mm Hg 101.48±6.76 103.33±10.11 *0.846
DBP, mm Hg 58.15±7.74 68.16±5.64 *0.325
Hemoglobin, g/dL 12.75±1.12 12.65±2.13 *0.843
Hematocrit, % 38.21±3.54 37.42±3.86 *0.926
FBS, mg/dL 90.92±7.19 88.73±8.42 *0.664
Triglyceride, mg/dL 76.92±28.04 80.21±30.23 *0.641
TC, mg/dL 144.96±28.52 140.02±31.24 *0.537
LDL-c, mg/dL 82.32±21.18 85.54±26.65 *0.848
HDL-c, mg/dL 45.24±7.54 42.86±6.42 *0.755

All variables are reported as the mean±standard deviation

*

Not significant (p>0.05). The normality of all data was assessed with the Kolmogorov–Smirnov test for normally distributed data and the nonparametric Mann–Whitney U test for non-normal data.

BMC - body mass index; DBP - diastolic blood pressure; FBS - fasting blood glucose; HDL-c - high density lipoprotein cholesterol; LDL-c - low density lipoprotein cholesterol; SBP - systolic blood pressure; TC - total cholesterol

HHS Vulnerability Disclosure